Cited by 152Drug Transport and Resistance MechanismsCannabis and Cannabinoid ResearchPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids

Open access

Holland, M L, Lau, D T T, Allen, J D, Arnold, J C·2007·British Journal of Pharmacology

DOI 10.1038/sj.bjp.0707467PMC PMC2190019

Open this paper in CoChat — free account Open PDF

Abstract

Background and purpose: Cannabinoids are used therapeutically for the palliation of the adverse side effects associated with cancer chemotherapy. However, cannabinoids also inhibit both the activity and expression of the multidrug transporter, P‐glycoprotein in vitro . Here we address the interaction of cannabinol (CBN), cannabidiol (CBD) and Δ 9 ‐tetrahydrocannabinol (THC) with the related multidrug transporter, ABCG2. Experimental approach: Cannabinoid inhibition of Abcg2/ABCG2 was assessed using flow cytometric analysis of substrate accumulation and ATPase activity assays. The cytotoxicity and chemosensitization by cannabinoids was determined with cell viability assays. Expression of cannabinoid and vanilloid receptors was assessed using reverse transcriptase polymerase chain reaction, and cannabinoid modulation of ABCG2 expression was examined using immunoblotting. Key results: CBN, CBD and THC increased the intracellular accumulation of the Abcg2/ABCG2 substrate, mitoxantrone, in an over‐expressing cell line. The THC metabolite, (−)‐11‐nor‐9‐carboxy‐Δ 9 ‐THC was much less potent. The plant cannabinoids inhibited both basal and substrate stimulated ATPase activity of human ABCG2. Cannabinoid cytotoxicity occurred in the absence of known cannabinoid cell surface receptors, and only at concentrations higher than those required for Abcg2/ABCG2 inhibition. Sub‐toxic concentrations of the cannabinoids resensitized the overexpressing cell line to the cytotoxic effect of Abcg2/ABCG2 substrates, mitoxantrone and topotecan. This occurred in the absence of any effect on ABCG2 expression. Conclusions and implications: Cannabinoids are novel Abcg2/ABCG2 inhibitors, reversing the Abcg2‐mediated multidrug‐resistant phenotype in vitro . This finding may have implications for the co‐administration of cannabinoids with pharmaceuticals that are ABCG2 substrates. British Journal of Pharmacology (2007) 152 , 815–824; doi: 10.1038/sj.bjp.0707467 ; published online 1 October 2007

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0707467

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. W. T. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,317
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T. A., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,372
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Cannabinoids: potential anticancer agents
Guzmán, M. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1188 · Cited by 721
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
Allen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 690
Self-citation
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 639
Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.
Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A., & Scarborough, G. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42909-2 · Cited by 633
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.16 · Cited by 610
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)
Litman, T., Brangi, M., Hudson, E., Fetsch, P. A., Abati, A. D., Ross, D. D., Miyake, K., Resau, J. H., & Bates, S. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2011 · Cited by 538
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp, M. C., Floot, B. G., & Schellens, J. H. M. (1999) · PubMed · Cited by 487
Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918
Kruijtzer, C. M. F., Beijnen, J. H., Rosing, H., Huinink, W. W. T. B., Schot, M. E., Jewell, R. C., Paul, E. M., & Schellens, J. H. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.116 · Cited by 465
Localisation of breast cancer resistance protein in microvessel endothelium of human brain
Cooray, H. C., Blackmore, C. G., Maskell, L. B., & Barrand, M. A. (2002) · Neuroreport · doi:10.1097/00001756-200211150-00014 · Cited by 419
A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
Guzmán, M., Duarte, M. C. L. F., Blázquez, C., Ravina, J., Rosa, M. C., Galve‐Roperh, I., Sánchez, C., Velasco, G., & González‐Feria, L. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603236 · Cited by 366
The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin.
Allen, J. D., Brinkhuis, R. F., Wijnholds, J., & Schinkel, A. H. (1999) · PubMed · Cited by 353
Self-citation
Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women
Wall, M. E., Sadler, B. M., Brine, D. R., Taylor, H. L., & Perez‐Reyes, M. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.179 · Cited by 346
Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
Robey, R. W., Medina-Pérez, W. Y., Nishiyama, K., Lahusen, T. J., Miyake, K., Litman, T., Senderowicz, A. M., Ross, D. D., & Bates, S. E. (2001) · PubMed · Cited by 341
Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded material
Diestra, J. E., Scheffer, G. L., Català, I., Maliepaard, M., Schellens, J. H. M., Scheper, R. J., Germa-Lluch, J. R., & Izquierdo, M. A. (2002) · The Journal of Pathology · doi:10.1002/path.1203 · Cited by 277
Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells
Kawabata, S., Oka, M., Shiozawa, K., Tsukamoto, K., Nakatomi, K., Soda, H., Fukuda, M., Ikegami, Y., Sugahara, K., Yamada, Y., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4267 · Cited by 242
Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles
Breedveld, P., Zelcer, N., Pluim, D., Sönmezer, Ö., Tibben, M. M., Beijnen, J. H., Schinkel, A. H., van Tellingen, O., Borst, P., & Schellens, J. H. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4062 · Cited by 230
Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22 and Nox4 Expression
McKallip, R. J., Jia, W., Schlomer, J., Warren, J. W., Nagarkatti, P. S., & Nagarkatti, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023937 · Cited by 230
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia
Steinbach, D., Sell, W., Voigt, A., Hermann, J., Zintl, F., & Sauerbrey, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402541 · Cited by 226
Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance.
Allen, J. D., Brinkhuis, R. F., van Deemter, L., Wijnholds, J., & Schinkel, A. H. (2000) · PubMed · Cited by 200
Self-citation
Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana
Zhu, H.-J., Wang, J.-S., Markowitz, J. S., Donovan, J. L., Gibson, B. B., Gefroh, H. A., & DeVane, C. L. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098541 · Cited by 192
Inhibitory effects of cannabinoid CB 1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis
Portella, G., Laezza, C., Laccetti, P., PETROCELLIS, L. D., Marzo, V. D., & Bifulco, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1129fje · Cited by 184
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
van den Heuvel‐Eibrink, M. M., Wiemer, E. A. C., Prins, A., Meijerink, J. P. P., Vossebeld, P. J. M., van der Holt, B., Pieters, R., & Sonneveld, P. (2002) · Leukemia · doi:10.1038/sj.leu.2402496 · Cited by 175
Sterol Transport by the Human Breast Cancer Resistance Protein (ABCG2) Expressed in Lactococcus lactis
Janvilisri, T., Venter, H., Shahi, S., Reuter, G., Balakrishnan, L., & van Veen, H. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301358200 · Cited by 158
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
Holland, M. L., Panetta, J. A., Hoskins, J. M., Bebawy, M., Roufogalis, B. D., Allen, J. D., & Arnold, J. C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.033 · Cited by 157
Self-citation
Δ9‐Tetrahydrocannabinol induces apoptosis in human prostate PC‐3 cells via a receptor‐independent mechanism
Ruiz, L., Miguel, A. E., & Díaz‐Laviada, I. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01073-x · Cited by 152
Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
Thomas, B. F., Compton, D. M., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23000-2 · Cited by 121
Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1)This paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Membrane Proteins in Health and Disease.
Sharom, F. J. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-199 · Cited by 108
Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2
Pál, Á., Méhn, D., Molnar, E. M., Gedey, S., Mészáros, P., Nagy, T., Glavinas, H., Janáky, T., von Richter, O., Báthori, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119289 · Cited by 107
Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2)
Woehlecke, H., Pohl, A., Alder‐Baerens, N., Lage, H., & Herrmann, A. (2003) · Biochemical Journal · doi:10.1042/bj20030886 · Cited by 94
Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor-1
Contassot, E., Wilmotte, R., Tenan, M., Belkouch, M., Schnüriger, V., de Tribolet, N., Bourkhardt, K., & Dietrich, P. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.956 · Cited by 67
??9-Tetrahydrocannabinol, 11-Hydroxy-??9-Tetrahydrocannabinol and 11-Nor-9-Carboxy-??9-Tetrahydrocannabinol in Human Plasma After Controlled Oral Administration of Cannabinoids
Goodwin, R. S., Gustafson, R. A., Barnes, A. J., Nebro, W., Moolchan, E. T., & Huestis, M. A. (2006) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200608000-00010 · Cited by 56
Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor-Δ9-carboxy tetrahydrocannabinol glucuronide
Skopp, G., Pötsch, L., Mauden, M., & Richter, B. (2002) · Forensic Science International · doi:10.1016/s0379-0738(02)00023-3 · Cited by 54
Modulation of P‐glycoprotein activity by cannabinoid molecules in HK‐2 renal cells
Nieri, P., Romiti, N., Adinolfi, B., Chicca, A., Massarelli, I., & Chieli, E. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706778 · Cited by 36

Flagged first, then by citations

Sorted by citations

Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 664
Molecular Targets of Cannabidiol in Neurological Disorders
Bih, C. I., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M. L., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 602
Safety and side effects of cannabidiol, a Cannabis sativa constituent
Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558
Cannabidiol Adverse Effects and Toxicity
Huestis, M. A., Solimini, R., Pichini, S., Pacifici, R., Carlier, J., & Busardò, F. P. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190603171901 · Cited by 499
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
Stout, S. M., & Cimino, N. M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.849268 · Cited by 350

See all 152

Authors: Holland, M. L., Lau, D. T. T., Allen, J. D., & Arnold, J. C.
Affiliations: The University of Sydney (AU)
Centenary Institute (AU)
Corresponding author: Arnold, J C
ORCID: Holland, M L
Arnold, J C
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2007-11
Volume: 152
Issue: 5
Pages: 815-824
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1038/sj.bjp.0707467
PMC: PMC2190019
OpenAlex: W1571533074
Cited by: 150
References: 38
Citations by year: 2026: 7 · 2025: 7 · 2024: 8 · 2023: 14 · 2022: 14 · 2021: 11 · 2020: 13 · 2019: 11 · 2018: 9 · 2017: 5 · 2016: 14 · 2015: 6 · 2014: 3 · 2013: 10 · 2012: 6
FWCI: 1.01
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 455 d)
Locations: British Journal of Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council
National Health and Medical Research Council
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords: ABCG2, multidrug transporter, cannabinol, cannabidiol, delta-9-tetrahydrocannabinol, multidrug resistance, chemosensitization, mitoxantrone, topotecan, cannabinoid receptors, vanilloid receptor, drug-drug interactions
MeSH terms: ATP Binding Cassette Transporter, Subfamily G, Member 2, Adenosine Triphosphatases, Animals, Cannabinoids, Cell Line, Cell Survival, Dose-Response Relationship, Drug, Flow Cytometry, Humans, Mitoxantrone, Neoplasm Proteins, Plant Extracts, Sulfasalazine, Dronabinol, Immunoblotting, ATP-Binding Cassette Transporters, Topotecan, Inhibitory Concentration 50, Reverse Transcriptase Polymerase Chain Reaction, Receptor, Cannabinoid, CB1, Cell Line, Tumor, TRPV Cation Channels, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks